PORTIA: A PHASE 1B STUDY EVALUATING SAFETY AND EFFICACY OF TISAGENLECLEUCEL AND PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
Jaeger, U., McGuirk, J., Worel, N., Riedell, P., Fleury, I., Borchmann, P., Forcina, A., Chu, J., Leung, M., Pacaud, L., Waller, E.Volume:
37
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.7_2632
Date:
June, 2019
File:
PDF, 98 KB
english, 2019